BioMarin Pharmaceutical Inc. / Parent Project Muscular Dystrophy / Merck Serono / Prosensa N.V. / Merck KGaA / Genzyme Corporation / Media Debra Charlesworth BioMarin Pharmaceutical Inc. / Investors Traci McCarty BioMarin Pharmaceutical Inc. / Prosensa Holding N.V. / /
Continent
Europe / /
Country
Germany / Netherlands / United States / /
Currency
USD / /
Event
Reorganization / FDA Phase / M&A / Conference Call / Business Partnership / General or Shareholder Meeting / Security Buyback / /
Facility
Prosensa’s pipeline / Prosensa’s headquarters / /
IndustryTerm
rare disease therapies / near-term opportunity / biotechnology / treatment of germline BRCA breast cancer / treatment of Lambert Eaton Myasthenic Syndrome / treatment of Pompe disease / therapeutics for the treatment of genetic disorders / preclinical products / potential products / therapies for people with devastating disorders / /